Lipoic acid as a novel treatment for mild cognitive impairment and early-stage Alzheimer’s disease

Micronutrients and Brain Health

Volumn , Issue , 2009, Pages 133-147

  Maczurek, Annette E ^a,b   Krautwald, Martina ^a   Steele, Megan L ^a,b   Hager, Klaus ^c   Kenklies, Marlene ^c   Sharman, Matt ^d   Martins, Ralph ^d   Engel, Jürgen ^e   Carlson, David ^f   Münch, Gerald ^a  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c Henriettenstiftung   (Germany)

^d EDITH COWAN UNIVERSITY   (Australia)

^e Zentaris GmbH   (Germany)

^f GeroNova Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650753613     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (70)

1. Stuchbury, G., and Münch, G., Alzheimer’s associated inflammation, potential drug targets and future therapies, J Neural Transm 112(3), 429-53, 2005.
2. Cummings, J. L., Treatment of Alzheimer’s disease: Current and future therapeutic approaches, Rev Neurol Dis 1(2), 60-9, 2004.
3. Retz, W., Gsell, W., Münch, G., Rosler, M., and Riederer, P., Free radicals in Alzheimer’s disease, J Neural Transm Suppl 54, 221-36, 1998.
4. Münch, G., Schinzel, R., Loske, C., Wong, A., Durany, N., Li, J. J., Vlassara, H., Smith, M. A., Perry, G., and Riederer, P., Alzheimer’s disease-Synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts, J Neural Transm 105(4-5), 439-61, 1998.
5. Wong, A., Luth, H. J., Deuther-Conrad, W., Dukic-Stefanovic, S., Gasic-Milenkovic, J., Arendt, T., and Münch, G., Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer’s disease, Brain Res 920(1-2), 32-40, 2001.
6. Griffin, W. S., Sheng, J. G., Roberts, G. W., and Mrak, R. E., Interleukin-1 expression in different plaque types in Alzheimer’s disease: Significance in plaque evolution, J Neuropathol Exp Neurol 54(2), 276-81, 1995.
7. Ishii, K., and Minoshima, S., PET is better than perfusion SPECT for early diagnosis of Alzheimer’s disease, Eur J Nucl Med Mol Imaging 32(12), 1463-5, 2005.
8. Nordberg, A., Nyberg, P., Adolfsson, R., and Winblad, B., Cholinergic topography in Alzheimer brains:A comparison with changes in the monoaminergic profile, J Neural Transm 69(1-2), 19-32, 1987.
9. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains, Neurosci Lett 72(1), 115-9, 1986.
10. Holmquist, L., Stuchbury, G., Berbaum, K., Muscat, S., Young, S., Hager, K., Engel, J., and Münch, G., Lipoic acid as a novel treatment for Alzheimer’s disease and related dementias, Pharmacol Ther 113(1), 154-64, 2007.
11. Packer, L., Witt, E. H., and Tritschler, H. J., alpha-Lipoic acid as a biological antioxidant, Free Radic Biol Med 19(2), 227-50, 1995.
12. Nguyen, T., Yang, C. S., and Pickett, C. B., The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress, Free Radic Biol Med 37(4), 433-41, 2004.
13. Chen, X. L., and Kunsch, C., Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: A new therapeutic approach for the treatment of inflammatory diseases, Curr Pharm Des 10(8), 879-91, 2004.
14. Haugaard, N., and Levin, R. M., Regulation of the activity of choline acetyl transferase by lipoic acid, Mol Cell Biochem 213(1-2), 61-3, 2000.
15. Haugaard, N., and Levin, R. M., Activation of choline acetyl transferase by dihydrolipoic acid, Mol Cell Biochem 229(1-2), 103-6, 2002.
16. Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E., and Bush, A. I., The A beta peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry 38(24), 7609-16, 1999.
17. Suh, J. H., Moreau, R., Heath, S. H., and Hagen, T. M., Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex, Redox Rep 10(1), 52-60, 2005.
18. Fonte, J., Miklossy, J., Atwood, C., and Martins, R., The severity of cortical Alzheimer’s type changes is positively correlated with increased amyloid-beta levels: Resolubilization of amyloid-beta with transition metal ion chelators, J Alzheimers Dis 3(2), 209-19, 2001.
19. Quinn, J. F., Bussiere, J. R., Hammond, R. S., Montine, T. J., Henson, E., Jones, R. E., and Stackman, R. W., Jr., Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice, Neurobiol Aging 28(2), 213-25, 2007.
20. Suh, J. H., Zhu, B. Z., deSzoeke, E., Frei, B., and Hagen, T. M., Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes, Redox Rep 9(1), 57-61, 2004.
21. Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., and Schmidt, A. M., Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress, J Biol Chem 272(28), 17810-4, 1997.
22. Wong, A., Dukic-Stefanovic, S., Gasic-Milenkovic, J., Schinzel, R., Wiesinger, H., Riederer, P., and Münch, G., Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia, Eur J Neurosci 14(12), 1961-7, 2001.
23. Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Muller, M., Wahl, P., Ziegler, R., and Nawroth, P. P., Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells, Diabetes 46(9), 1481-90, 1997.
24. Cao, Z., Tsang, M., Zhao, H., and Li, Y., Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: Protection against oxidative injury, Biochem Biophys Res Commun 310(3), 979-85, 2003.
25. Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R. M., and Hagen, T. M., Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid, Proc Natl Acad Sci U S A 101(10), 3381-6, 2004.
26. Suh, J. H., Wang, H., Liu, R. M., Liu, J., and Hagen, T. M., (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: Evidence for increased cysteine requirement for GSH synthesis, Arch Biochem Biophys 423(1), 126-35, 2004.
27. Pocernich, C. B., and Butterfield, D. A., Acrolein inhibits NADH-linked mitochondrial enzyme activity:Implications for Alzheimer’s disease, Neurotox Res 5(7), 515-20, 2003.
28. Arivazhagan, P., Ramanathan, K., and Panneerselvam, C., Effect of dl-alpha-lipoic acid on glutathione metabolic enzymes in aged rats, Exp Gerontol 37(1), 81-7, 2001.
29. Hoyer, S., Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis, J Neural Transm 105(4-5), 415-22, 1998.
30. Watson, G. S., and Craft, S., The role of insulin resistance in the pathogenesis of Alzheimer’s disease:Implications for treatment, CNS Drugs 17(1), 27-45, 2003.
31. Craft, S., Asthana, S., Cook, D. G., Baker, L. D., Cherrier, M., Purganan, K., Wait, C., Petrova, A., Latendresse, S., Watson, G. S., Newcomer, J. W., Schellenberg, G. D., and Krohn, A. J., Insulin doseresponse effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: Interactions with apolipoprotein E genotype, Psychoneuroendocrinology 28(6), 809-22, 2003.
32. Bitar, M. S., Wahid, S., Pilcher, C. W., Al-Saleh, E., and Al-Mulla, F., Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats, Horm Metab Res 36(8), 542-9, 2004.
33. Seaton, T. A., Jenner, P., and Marsden, C. D., The isomers of thioctic acid alter C-deoxyglucose incorporation in rat basal ganglia, Biochem Pharmacol 51(7), 983-6, 1996.
34. Aliev, G., Liu, J., Shenk, J. C., Fischbach, K., Pacheco, G. J., Chen, S. G., Obrenovich, M. E., Ward, W. F., Richardson, A. G., Smith, M. A., Gasimov, E., Perry, G., and Ames, B. N., Neuronal mitochondrial amelioration by feeding acetyl-l-carnitine and lipoic acid to aged rats, J Cell Mol Med, 320-33, 2008.
35. Hoyer, S., Memory function and brain glucose metabolism, Pharmacopsychiatry 36 Suppl 1, S62-7, 2003.
36. Zhang, L., Xing, G. Q., Barker, J. L., Chang, Y., Maric, D., Ma, W., Li, B. S., and Rubinow, D. R., Alphalipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway, Neurosci Lett 312(3), 125-8, 2001.
37. Lovell, M. A., Xie, C., Xiong, S., and Markesbery, W. R., Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid, J Alzheimers Dis 5(3), 229-39, 2003.
38. Muller, U., and Krieglstein, J., Prolonged pretreatment with alpha-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury, J Cereb Blood Flow Metab 15(4), 624-30, 1995.
39. Hagen, T. M., Ingersoll, R. T., Lykkesfeldt, J., Liu, J., Wehr, C. M., Vinarsky, V., Bartholomew, J. C., and Ames, A. B., (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate, FASEB J 13(2), 411-8, 1999.
40. Liu, J., Killilea, D. W., and Ames, B. N., Age-associated mitochondrial oxidative decay: Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-lcarnitine and/or R-alpha-lipoic acid, Proc Natl Acad Sci U S A 99(4), 1876-81, 2002.
41. Farr, S. A., Poon, H. F., Dogrukol-Ak, D., Drake, J., Banks, W. A., Eyerman, E., Butterfield, D. A., and Morley, J. E., The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice, J Neurochem 84(5), 1173-83, 2003.
42. Hager, K., Marahrens, A., Kenklies, M., Riederer, P., and Münch, G., Alpha-lipoic acid as a new treatment option for Alzheimer type dementia, Arch Gerontol Geriatr 32(3), 275-282, 2001.
43. Hager, K., Kenklies, M., McAfoose, J., Engel, J., and Münch, G., Alpha-lipoic acid as a new treatment option for Alzheimer’s disease-A 48 months follow-up analysis, J Neural Transm Suppl (72), 189-93, 2007.
44. Krone, D., The pharmacokinetics and pharmacodynamics of R-(+)-alpha lipoic acid, Ph.D. thesis, Johann Wolfgang Goethe University, Frankfurt, Germany, 2002.
45. Yadav, V., Marracci, G., Lovera, J., Woodward, W., Bogardus, K., Marquardt, W., Shinto, L., Morris, C., and Bourdette, D., Lipoic acid in multiple sclerosis: A pilot study, Mult Scler 11, 159-65, 2005.
46. Chen, J., Jiang, W., Cai, J., Tao, W., Gao, X., and Jiang, X., Quantification of lipoic acid in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci 824(1-2), 249-57, 2005.
47. Carlson, D. A., Smith, A. R., Fischer, S. J., Young, K. L., and Packer, L., The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects, Altern Med Rev 12(4), 343-51, 2007.
48. Hermann, R., Niebch, G., and Borbe, H., Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers, Eur J Pharm Sci 4, 167-174, 1996.
49. DeFronzo, R. A., Tobin, J. D., and Andres, R., Glucose clamp technique: A method for quantifying insulin secretion and resistance, Am J Physiol 237(3), E214-23, 1979.
50. Ziegler, D., Thioctic acid for patients with symptomatic diabetic polyneuropathy: A critical review, Treat Endocrinol 3(3), 173-89, 2004.
51. Carlson, D., Young, K., Fischer, S., and Ulrich, H., An Evaluation of the Stability and Plasma Pharmacokinetics of R-Lipoic Acid (RLA) and R-Dihydrolipoic Acid (R-DHLA) Dosage Forms in Human Plasma from Healthy Volunteers, Taylor & Francis, Boca Raton, FL, 2008.
52. Steele, M., Stuchbury, G., and Münch, G., The molecular basis of the prevention of Alzheimer’s disease through healthy nutrition, Exp Gerontol 42(1-2), 28-36, 2007.
53. Ferrari, C. K., Functional foods, herbs and nutraceuticals: Towards biochemical mechanisms of healthy aging, Biogerontology 5(5), 275-89, 2004.
54. Liu, R. H., Potential synergy of phytochemicals in cancer prevention: Mechanism of action, J Nutr 134(12), 3479S-85S, 2004.
55. Solfrizzi, V., Panza, F., and Capurso, A., The role of diet in cognitive decline, J Neural Transm 110(1), 95-110, 2003.
56. Dai, Q., Borenstein, A. R., Wu, Y., Jackson, J. C., and Larson, E. B., Fruit and vegetable juices and Alzheimer’s disease: The Kame Project, Am J Med 119(9), 751-9, 2006.
57. Ng, T. P., Chiam, P. C., Lee, T., Chua, H. C., Lim, L., and Kua, E. H., Curry consumption and cognitive function in the elderly, Am J Epidemiol 164(9), 898-906, 2006.
58. Maclean, C. H., Issa, A. M., Newberry, S. J., Mojica, W. A., Morton, S. C., Garland, R. H., Hilton, L. G., Traina, S. B., and Shekelle, P. G., Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases, Evid Rep Technol Assess (Summ) (114), 1-3, 2005.
59. Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H., and Markesbery, W. R., Regional membrane phospholipid alterations in Alzheimer’s disease, Neurochem Res 23(1), 81-8, 1998.
60. Tully, A. M., Roche, H. M., Doyle, R., Fallon, C., Bruce, I., Lawlor, B., Coakley, D., and Gibney, M. J., Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer’s disease: A case-control study, Br J Nutr 89(4), 483-9, 2003.
61. Levites, Y., Amit, T., Mandel, S., and Youdim, M. B., Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate, FASEB J 17(8), 952-4, 2003.
62. Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., Hardy, J., Town, T., and Tan, J., Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice, J Neurosci 25(38), 8807-14, 2005.
63. Mandel, S., Weinreb, O., Amit, T., and Youdim, M. B., Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: Implications for neurodegenerative diseases, J Neurochem 88(6), 1555-69, 2004.
64. Zhao, B. L., Li, X. J., He, R. G., Cheng, S. J., and Xin, W. J., Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals, Cell Biophys 14(2), 175-85, 1989.
65. Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., and Cole, G. M., Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo, J Biol Chem 280(7), 5892-901, 2005.
66. Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., and Cole, G. M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse, J Neurosci 21(21), 8370-7, 2001.
67. Florent, S., Malaplate-Armand, C., Youssef, I., Kriem, B., Koziel, V., Escanye, M. C., Fifre, A., Sponne, I., Leininger-Muller, B., Olivier, J. L., Pillot, T., and Oster, T., Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers, J Neurochem 96(2), 385-95, 2006.
68. 1 in neural cell survival and Alzheimer disease, J Clin Invest 115(10), 2774-83, 2005.
69. Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N., Jr., Ashe, K. H., Frautschy, S. A., and Cole, G. M., Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model, Neuron 43(5), 633-45, 2004.
70. Lim, G. P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O., Salem, N., Jr., Frautschy, S. A., and Cole, G. M., A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model, J Neurosci 25(12), 3032-40, 2005.